Skip to content
Screener

Simulations Plus SLP Discovery — Revenue

Other product segments

Development
$17.07M+10.8%
Commercialization
$2.06M+1.8%
Clinical Operations
$277K-33.4%

Similar metrics at other companies

Oracle logo
ORCLCloud Revenues — Revenue
$9.91B+47.1%
Oracle logo
ORCLSoftware Revenues — Revenue
$6.82B-2.1%
Blue Owl Capital logo
OWLPerformance revenues — Revenue
$6.07M-3.9%
EAT
EATFranchise revenues — Revenue
$14.7M+21.5%
Cinemark Holdings logo
CNKOther Revenues — Revenue
$113.1M+18.2%
American Electric Power logo
AEPCommercial Revenues — Revenue
$1.21B+15.4%

Other financials

Income statement

See full
Revenue$21.9M+7.5%
Gross profit$15.1M+16.1%
Operating income$4.5M+106%
Net income$3.6M+105%
EPS (diluted)$0.18+105%

Balance sheet

See full
Cash & equivalents$35.3M+31.1%
Total debt$487.0K-32.3%
Total equity$139.0M+12.3%
Total assets$153.0M+13.9%

Cash flow

See full
Operating cash flow$8.7M+6.9%
CapEx$93.0K-68.7%
Free cash flow$8.6M+9.8%

Valuation

See full
Market cap$371.13M+32.9%
Enterprise value$336.29M+33.0%
P/E45.8×
P/S4.5×+1.0×

Profitability

See full
Gross margin63.4%+9.6pp
Operating margin13.2%
Net margin9.9%+5.2pp
FCF margin29.9%+12.8pp

Returns & leverage

See full
Return on equity6.2%+3.3pp
Debt / equity0.0×
Current ratio5.5×+0.4×

Where this comes from

Reported directly by Simulations Plus in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Simulations Plus’s 10-Q, filed July 9, 2026.

Filed
Jul 9, 2026, 4:10 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0001023459-26-000038
(in thousands)For the three months ended / May 31, 2026For the three months ended / % of total*For the three months ended / May 31, 2025For the three months ended / % of total
Discovery$2,48420%$2,52720%
Development9,81378%9,63177%
Clinical Operations2772%4163%
Commercialization3441
Total Software12,608100%12,615100%
Discovery
Development7,25578%5,76874%
Commercialization2,02322%1,98026%

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Simulations Plus's discovery — revenue?
Simulations Plus (SLP) reported discovery — revenue of $2.48M in Q1 2026.
How has Simulations Plus's discovery — revenue changed year-over-year?
Simulations Plus's discovery — revenue decreased by 1.7% year-over-year, from $2.53M to $2.48M.
What does discovery — revenue mean?
This metric represents the total revenue generated specifically from the Discovery segment, which focuses on software and consulting services for early-stage pharmaceutical research. It serves as a key indicator of the company's ability to monetize its specialized research tools and expertise within the drug discovery pipeline. Growth in this segment reflects successful market adoption of discovery-phase solutions and the expansion of the client base in the preclinical research market.

Ask your AI about Simulations Plus's discovery — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude